The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...
Local health boards invited adults aged 75–79, including those turning 75 before July 2025, to come forward for their free ...
Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...
A vaccination programme introduced to protect babies and older adults against a dangerous respiratory disease has cut ...
A new immunization for respiratory syncytial virus (RSV) is proving highly effective in preventing severe cases in infants.
Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.
The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.
What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...
Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...
High uptake of RSVpreF vaccine and nirsevimab was observed, with 64% of pregnant individuals and 70% of infants receiving ...